🍽🦠 PubMed Studies Citing Bacteria Shifts for 5,6-dihydro-9,10-dimethoxybenzo[g]-1,3-benzodioxolo[5,6-a]quinolizinium {Berberine} - Escherichia coli 2-222-05_S1_C3

Citations are updated once a week. Recently added citations may not appear.

8 Citations Found, Full List Requires Login Summary Publisher Link Html Article Download Article Why do I only have some/no links buttons showing?
πŸ““ - Direct Citation   |   πŸ‘ͺ - Infer Parent  |   πŸ‘Ά - Infer Child |   βš—οΈ - Inferred from bacteria association
For Samples: 😁 - Shifts in right direction   |   😒 - Shifts in wrong direction
Context Citation
5,6-dihydro-9,10-dimethoxybenzo[g]-1,3-benzodioxolo[5,6-a]quinolizinium {Berberine} - Escherichia coli 2-222-05_S1_C3    👶 Characterization and antioxidant activity of nano-formulated berberine and cyperus rotundus extracts with anti-inflammatory effects in mastitis-induced rats.
Scientific reports (Sci Rep ) Vol: 14 Issue 1 Pages: 18462
Pub: 2024 Aug 9 Epub: 2024 Aug 9 Authors Hashem AE , Elmasry IH , Lebda MA , El-Karim DRSG , Hagar M , Ebied SKM , Alotaibi BS , Rizk NI , Ghamry HI , Shukry M , Edres HA ,
Html Article Publication
5,6-dihydro-9,10-dimethoxybenzo[g]-1,3-benzodioxolo[5,6-a]quinolizinium {Berberine} - Escherichia coli 2-222-05_S1_C3    👶 Synthesis of New Derivatives of Berberine Canagliflozin and Study of Their Antibacterial Activity and Mechanism.
Molecules (Basel, Switzerland) (Molecules ) Vol: 29 Issue 1 Pages:
Pub: 2024 Jan 4 Epub: 2024 Jan 4 Authors Li J , Hou X , Xiao J , Zhu L , Deng Y , Li Z , Zhao Z , Luo Z , Wei H ,
Html Article Publication
5,6-dihydro-9,10-dimethoxybenzo[g]-1,3-benzodioxolo[5,6-a]quinolizinium {Berberine} - Escherichia coli 2-222-05_S1_C3    👶 Berberine: An inspiring resource for the treatment of colorectal diseases.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie (Biomed Pharmacother ) Vol: 167 Issue Pages: 115571
Pub: 2023 Nov Epub: 2023 Sep 25 Authors Cao F , Xia W , Dai S , Wang C , Shi R , Yang Y , Guo C , Xu XL , Luo J ,
Publication
5,6-dihydro-9,10-dimethoxybenzo[g]-1,3-benzodioxolo[5,6-a]quinolizinium {Berberine} - Escherichia coli 2-222-05_S1_C3    👶 Assessment of berberine as a multi-target antimicrobial: a multi-omics study for drug discovery and repositioning.
Omics : a journal of integrative biology (OMICS ) Vol: 18 Issue 1 Pages: 42-53
Pub: 2014 Jan Epub: 2013 Nov 16 Authors Karaosmanoglu K , Sayar NA , Kurnaz IA , Akbulut BS ,
Publication
5,6-dihydro-9,10-dimethoxybenzo[g]-1,3-benzodioxolo[5,6-a]quinolizinium {Berberine} - Escherichia coli 2-222-05_S1_C3    👶 Potential antibacterial activity of berberine against multi drug resistant enterovirulent Escherichia coli isolated from yaks (Poephagus grunniens) with haemorrhagic diarrhoea.
Asian Pacific journal of tropical medicine (Asian Pac J Trop Med ) Vol: 6 Issue 4 Pages: 315-9
Pub: 2013 Apr 13 Epub: Authors Bandyopadhyay S , Patra PH , Mahanti A , Mondal DK , Dandapat P , Bandyopadhyay S , Samanta I , Lodh C , Bera AK , Bhattacharyya D , Sarkar M , Baruah KK ,
Publication

BOOM

All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.

Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine

This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.

Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β€―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.


The awesome web hosting site that we use. Try it if you need to host (or unhappy with current provider)